These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2721804

  • 1. Acetylator phenotype in psoriasis.
    Jiménez-Nieto LC, Ladero JM, Fernández-Gundín MJ, Robledo A.
    Dermatologica; 1989; 178(3):136-7. PubMed ID: 2721804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acetylator polymorphism in Parkinson's disease.
    Ladero JM, Jimenez FJ, Benitez J, Fernandez-Gundin MJ, Martinez C, Llerena A, Cobaleda J, Muñoz JJ.
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [Abstract] [Full Text] [Related]

  • 4. Hepatic acetylator polymorphism in breast cancer patients.
    Ladero JM, Fernández MJ, Palmeiro R, Muñoz JJ, Jara C, Lázaro C, Pérez-Manga G.
    Oncology; 1987; 44(6):341-4. PubMed ID: 3684174
    [Abstract] [Full Text] [Related]

  • 5. Hepatic acetylator phenotype in bladder cancer patients.
    Ladero JM, Kwok CK, Jara C, Fernandez L, Silmi AM, Tapia D, Uson AC.
    Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
    [Abstract] [Full Text] [Related]

  • 6. Acetylator polymorphism in Alzheimer's disease.
    Ladero JM, Barquero MS, Coria F, Molina JA, Jiménez-Jiménez FJ, Benítez J.
    Eur J Med; 1993 May; 2(5):281-3. PubMed ID: 8252158
    [Abstract] [Full Text] [Related]

  • 7. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH, Gordon GR, Lin E, Green CE, Tyson CA.
    Anticancer Res; 1990 May; 10(1):225-9. PubMed ID: 2334132
    [Abstract] [Full Text] [Related]

  • 8. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW.
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [Abstract] [Full Text] [Related]

  • 9. Acetylation.
    Weber WW.
    Birth Defects Orig Artic Ser; 1990 Apr; 26(1):43-65. PubMed ID: 2224079
    [Abstract] [Full Text] [Related]

  • 10. Acetylator polymorphism in multiple sclerosis.
    Ladero JM, Arroyo R, De Andrés C, Jiménez-Jiménez FJ, Molina JA, Varela de Seijas E, Giménez-Roldán S, Benítez J.
    Acta Neurol Scand; 1994 Feb; 89(2):102-4. PubMed ID: 8191871
    [Abstract] [Full Text] [Related]

  • 11. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
    Lil'in ET, Korsunskaia MP, Meksin VA, Drozdov ES, Nazarov VV.
    Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
    [Abstract] [Full Text] [Related]

  • 12. The association of the slow acetylator phenotype with bladder cancer.
    Evans DA, Eze LC, Whibley EJ.
    J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
    [Abstract] [Full Text] [Related]

  • 13. Drug acetylation and expression of lupus erythematosus.
    Marsden JR, Mason GG, Coburn PR, Rawlins MD, Shuster S.
    Eur J Clin Pharmacol; 1985 Oct; 28(4):387-90. PubMed ID: 4029245
    [Abstract] [Full Text] [Related]

  • 14. Acetylation polymorphism and leprosy.
    Eze LC, Okpogba AN, Ogan AU.
    Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
    [Abstract] [Full Text] [Related]

  • 15. The relationship between the acetylator and the sparteine hydroxylation polymorphisms.
    Harmer D, Evans DA, Eze LC, Jolly M, Whibley EJ.
    J Med Genet; 1986 Apr; 23(2):155-6. PubMed ID: 3712391
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L, Szórády I, Sánta A, Barkai L, Vámosi I.
    Child Nephrol Urol; 1992 Apr; 12(4):192-6. PubMed ID: 1473091
    [Abstract] [Full Text] [Related]

  • 18. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A, Basci NE, Kalan S, Tuncer M, Kayaalp SO.
    Eur J Clin Pharmacol; 1990 Apr; 38(1):53-6. PubMed ID: 2328748
    [Abstract] [Full Text] [Related]

  • 19. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E, Brysová V, Utĕsený J, Macků M.
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [Abstract] [Full Text] [Related]

  • 20. Polymorphically acetylated aminoglutethimide in humans.
    Coombes RC, Foster AB, Harland SJ, Jarman M, Nice EC.
    Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.